People of all ages experience migraine, and the symptoms in children are similar to those in adults. Around 3-10% of children experience this health issue. However, the cause of migraine in ...

[22] Recently, the efficacy and safety of LCT for pediatric migraine was evaluated in a population of 30 children or adolescents aged 6 to 19 years (mean 12.9 years). This was a 10-week ...

Additionally, no adverse events were reported in this study. “For children and adolescents, uncontrolled migraine disease can negatively impact life trajectory and potentially lead to other ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief and 36% (9/25) reported consistent freedom from headache. The Food and Drug Administration (FDA) has ...

The U.S. Food and Drug Administration has expanded the age indication for Theranica's Nerivio, making it the first and only ...